| scholarly article | Q13442814 |
| P2093 | author name string | Mandana Khalili | |
| Sarah Schaeffer | |||
| P2860 | cites work | Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart Association | Q22306356 |
| Telaprevir for previously untreated chronic hepatitis C virus infection | Q29619800 | ||
| The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
| Sustained virological response rate to pegylated interferon plus ribavirin for chronic hepatitis C in African Americans: results in treatment-naïve patients in a university liver clinic | Q30482997 | ||
| Chronic hepatitis C treatment patterns in African American patients: an update | Q33212476 | ||
| Hepatitis C in African Americans: summary of a workshop | Q34071768 | ||
| Formal Patient Education Improves Patient Knowledge of Hepatitis C in Vulnerable Populations | Q34435133 | ||
| Comparison of characteristics of treated and non-treated patients with Hepatitis C infection | Q36246577 | ||
| Offers of hepatitis C care do not lead to treatment | Q36440941 | ||
| Formal hepatitis C education enhances HCV care coordination, expedites HCV treatment and improves antiviral response | Q36955116 | ||
| Racial differences in hepatitis C treatment eligibility | Q37077462 | ||
| Health disparities in liver disease: Time to take notice and take action | Q37249688 | ||
| Reasons why patients infected with chronic hepatitis C virus choose to defer treatment: do they alter their decision with time? | Q40234175 | ||
| Overcoming barriers to care for hepatitis C. | Q42981735 | ||
| Racial differences in liver inflammation and fibrosis related to chronic hepatitis C. | Q42985436 | ||
| Sofosbuvir for previously untreated chronic hepatitis C infection | Q42995119 | ||
| Reasons for non-treatment of hepatitis C in veterans in care | Q45227679 | ||
| African Americans may differ in their reasons for declining hepatitis C therapy compared to non-African Americans | Q45867712 | ||
| Chronic hepatitis C in Latinos: natural history, treatment eligibility, acceptance, and outcomes. | Q46038653 | ||
| Healthcare reform with a safety net: lessons from San Francisco | Q46189551 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 234-242 | |
| P577 | publication date | 2015-03-01 | |
| P1433 | published in | Annals of hepatology : official journal of the Mexican Association of Hepatology | Q15762182 |
| P1476 | title | Reasons for HCV non-treatment in underserved African Americans: implications for treatment with new therapeutics | |
| P478 | volume | 14 |
| Q91640011 | Clinical and Economic Burden of Patients with Chronic Hepatitis C with Versus Without Antiviral Treatment in Japan: An Observational Cohort Study Using Hospital Claims Data |
| Q53685191 | Direct Acting Antivirals Improve HCV Treatment Initiation and Adherence Among Underserved African Americans. |
| Q54945179 | Estimates of state-level chronic hepatitis C virus infection, stratified by race and sex, United States, 2010. |
| Q90095540 | Hepatitis C Virus Prevalence in 50 U.S. States and D.C. by Sex, Birth Cohort, and Race: 2013-2016 |
| Q59356778 | Ledipasvir/Sofosbuvir Effectively Treats Hepatitis C Virus Infections in an Underserved Population |
| Q40169020 | Neighborhood Inequalities in Hepatitis C Mortality: Spatial and Temporal Patterns and Associated Factors |
| Q36654120 | Non-initiation of hepatitis C virus antiviral therapy in patients with human immunodeficiency virus/hepatitis C virus co-infection |
| Q40419188 | Racial-Ethnic Disparities in Uptake of New Hepatitis C Drugs in Medicare |
| Q40064478 | Regional differences in treatment rates for patients with chronic hepatitis C infection: Systematic review and meta-analysis |
| Q57841241 | Sofosbuvir based regimens in the treatment of chronic hepatitis C genotype 1 infection in African-American patients: a community-based retrospective cohort study |
Search more.